Osteoarthritis is the most common degenerative joint disease, affecting 22% of adults over 40 globally. Although the condition has been extensively studied through a medical perspective, the molecular changes associated with osteoarthritis remain unclear.
Do system-level DOAC therapy management services affect anticoagulation outcomes for AF patients compared to usual care?
Researchers compared outcomes related to three direct oral anticoagulant (DOAC) care models.
July 10, 2023